SPECIALITY MEDICINES LIMITED (SPML)

BSE: ₹220.10
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 44.78
YOY Revenue Growth % -
Other Income 0.70
Total Income 45.49
Total Expenses + 37.39
Cost of Materials Consumed 0.00
Employee Benefit Expense 0.96
Other Expenses 2.73
Operating Profit 7.40
OPM % 16.5%
Profit Before Tax + 8.10
Tax Expense 8.10
Tax % 100%
Profit After Tax 0.00
EPS (Basic) 12.54

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 75.29
YOY Revenue Growth % -
Other Income 0.83
Total Income 76.11
Total Expenses + 63.10
Employee Benefit Expense 1.73
Other Expenses 5.74
Operating Profit 12.19
OPM % 16.2%
Profit Before Exceptional 0.00
Exceptional Items 0.00
Profit Before Tax + 13.02
Tax Expense 13.02
Tax % 100%
Profit After Tax 0.00
EPS (Basic) 20.11

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 6.26
Property, Plant & Equipment 1.71
Capital Work in Progress 0.00
Non-Current Investments 0.30
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 88.97
Inventories 28.32
Trade Receivables 0.00
Cash and Cash Equivalents 24.55
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 0.00
Other Equity 0.00
Non-Current Liabilities 5.20
Current Liabilities 18.83
Total Liabilities 0.00

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities -1.28
Cash from Investing Activities -2.83
Cash from Financing Activities 27.82
Net Increase/Decrease in Cash 23.70